At the end of follow-up , changes in the mean of systolic ( -2.1 vs. 3.9 % mmHg , p < 0.05 ) and diastolic ( -3.8 vs. 7.5 % mmHg , p < 0.05 ) blood pressures , HOMA-IR index ( -46.5 vs. -5.4 % , p < 0.0001 ) , fasting glucose ( -12.3 vs. -1.8 % mg/dL , p < 0.05 ) and triglyceride levels ( -47.4 % vs. 10.1 % mg/dL , p < 0.0001 ) were significantly lower in the subjects who received MgCl2 compared with individuals in the control group .